Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cidara Therapeutics, Inc. - Common Stock (NQ:CDTX)

217.91 +0.20 (+0.09%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,488,261
Open 217.41
Bid (Size) 217.53 (800)
Ask (Size) 218.00 (200)
Prev. Close 217.71
Today's Range 217.41 - 218.77
52wk Range 14.33 - 218.85
Shares Outstanding 49,506,268
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
This Fund Sold $49 Million of Cidara Stock — Then Merck Announced a $9.2 Billion Takeover ↗
One biotech-focused investment firm cashed out of its stake in this drug developer as the stock soared—but seemingly missed out on a massive premium by mere weeks. 
Via The Motley Fool
News headline image
Top 2 Health Care Stocks That May Fall Off A Cliff This Month ↗
 
Via Benzinga

Performance

YTD
+698.2%
+698.2%
1 Month
+114.6%
+114.6%
3 Month
+244.6%
+244.6%
6 Month
+722.6%
+722.6%
1 Year
+1356.6%
+1356.6%

More News

Read More
Cidara Therapeutics Stock Rockets Over 700% This Year — Then Wall Street Turns Neutral On Merck Takeover ↗
Via Stocktwits
News headline image
Cidara Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cidara Therapeutics, Inc. - CDTX
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Earnings Scheduled For November 6, 2025 ↗
Via Benzinga
News headline image
Top movers analysis one hour before the close of the markets on 2025-11-14: top gainers and losers in today's session. ↗
Via Chartmill
News headline image
Which stocks are moving on Friday? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Via Benzinga
News headline image
Gold Tumbles Over 2%; Cidara Therapeutics Shares Spike Higher ↗
Via Benzinga
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Cidara Therapeutics, Inc. (Nasdaq - CDTX), Mersana Therapeutics, Inc. (Nasdaq - MRSN), TreeHouse Foods Inc. (NYSE - THS), Gulf Island Inc. (Nasdaq - GIFI)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
News headline image
Merck Swoops In On Buyout Bonanza With A $9.2 Billion Cidara Therapeutics Deal ↗
Via Investor's Business Daily
News headline image
Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday ↗
Via Benzinga
News headline image
Nasdaq Dips Over 300 Points; Applied Materials Posts Upbeat Q4 Earnings ↗
Via Benzinga
News headline image
Merck Makes Big Bet On Flu Protection With Cidara Buyout ↗
Via Benzinga
News headline image
Discover the top movers in Friday's pre-market session. ↗
Via Chartmill
News headline image
CDTX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Cidara Therapeutics, Inc. is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Via Benzinga
News headline image
Merck To Buy Cidara In $9.2B Deal To Strengthen Antiviral Portfolio ↗
Via Stocktwits
Topics Intellectual Property
News headline image
Why RLX Technology Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Why Is Cidara Therapeutics (CDTX) Stock Trending Overnight? ↗
Via Benzinga
Cidara Therapeutics Stock Soars 42% After-Hours On Merck Buyout Buzz — Retail Traders Eye A Potential Blowout Premium ↗
Via Stocktwits
News headline image
Janus Henderson, Avidity Biosciences, BridgeBio Pharma And Other Big Stocks Moving Higher On Monday ↗
Via Benzinga
News headline image
Cidara Therapeutics Analyst Says Lead Influenza Candidate Is 'Strategically Attractive' ↗
Via Benzinga
News headline image
Cidara Therapeutics Surges Ahead of ESWI 2025 Presentation and JP Morgan Coverage ↗
Via Benzinga

Frequently Asked Questions

Is Cidara Therapeutics, Inc. - Common Stock publicly traded?
Yes, Cidara Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Cidara Therapeutics, Inc. - Common Stock trade on?
Cidara Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cidara Therapeutics, Inc. - Common Stock?
The ticker symbol for Cidara Therapeutics, Inc. - Common Stock is CDTX on the Nasdaq Stock Market
What is the current price of Cidara Therapeutics, Inc. - Common Stock?
The current price of Cidara Therapeutics, Inc. - Common Stock is 217.91
When was Cidara Therapeutics, Inc. - Common Stock last traded?
The last trade of Cidara Therapeutics, Inc. - Common Stock was at 11/17/25 04:00 PM ET
What is the market capitalization of Cidara Therapeutics, Inc. - Common Stock?
The market capitalization of Cidara Therapeutics, Inc. - Common Stock is 10.79B
How many shares of Cidara Therapeutics, Inc. - Common Stock are outstanding?
Cidara Therapeutics, Inc. - Common Stock has 11B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.